Collaborome ApS
CVRCVR number44779986Opløst
Company financials
Key figures
Updated 27 Jun 2025
- Return on assets
- -35.1%
- Return on equity
- -42.4%
- Current ratio
- –
- Equity ratio
- 98.7%
Profit and loss
| Reporting period | |
|---|---|
Revenue | 0 |
Gross profit | -10,000 |
Operating profit | -10,000 |
Finance income | -16 |
Tax expense | 0 |
Profit/loss for the year | -11,910 |
Employees
| Reporting period | |
|---|---|
Personnel costs | 0 DKK |
Balance sheet
| Reporting period | |
|---|---|
Cash and cash equivalents | 25,956 |
Current assets | 28,456 |
Non-current assets | 0 |
Total assets | 28,456 |
Equity | 28,092 |
Liabilities | 364 |
Current liabilities | 0 |
Working capital
| Reporting period | |
|---|---|
Inventories | 0 |
Trade receivables | 0 |
Other current receivables | 0 |
Trade payables | 0 |
Capital and dividend
| Reporting period | |
|---|---|
Contributed capital | 40,002 |
Retained earnings | -11,910 |
Investments and assets
| Reporting period | |
|---|---|
Long-term investments and receivables | 0 |
Property, plant and equipment | 0 |
Annual report highlights
Official annual report · 2024
Business and development
Primary activities
At overføre forskingsresultater fra projekt på Københavns Universitet i forbindelse med ansøgning om støtte til kommecialisering af Collaborome projektet.
Development in activities and financial affairs
Der har været et højere forbrug end forventet. Der var ikke forventet nogle indtægter i indeværende år.
Risks and material matters
Significant events after the reporting period
Der er truffet beslutning om at nedlukke virksomheden, da formålet for virksomhedens drift ikke længere er til stede.